Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Syntimmune
4447
Syntimmune
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
Founded in 2013, Syntimmune is the worlds leader in the biology of the neonatal Fc receptor (FcRn). Syntimmune's lead program targets FcRn.
Suggest edits
Founded
2013
Raised
$84M
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Kickstarter
Wired
Goldman Sachs
Bloomberg
JPMorgan
Time Warner
The New York Times
Companies in the same industry
Esperion Therapeutics
Credence MedSystems
myMatrixx
Provia Laboratories
molecular assemblies
Impedans
3D Bio Holdings
Tricida, Inc.
Viventia Bio Inc.
Suzhou Zelgen Biopharmaceuticals
Alexa global traffic share
